Brevan Howard Capital Management LP Sells 19,491 Shares of HCA Healthcare, Inc. $HCA

Brevan Howard Capital Management LP trimmed its holdings in HCA Healthcare, Inc. (NYSE:HCA) by 57.1% in the third quarter, HoldingsChannel.com reports. The institutional investor owned 14,621 shares of the company’s stock after selling 19,491 shares during the period. Brevan Howard Capital Management LP’s holdings in HCA Healthcare were worth $6,231,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds have also added to or reduced their stakes in the company. Cerity Partners LLC grew its stake in HCA Healthcare by 13.1% in the 3rd quarter. Cerity Partners LLC now owns 43,920 shares of the company’s stock valued at $18,719,000 after buying an additional 5,092 shares during the last quarter. Swiss National Bank grew its position in shares of HCA Healthcare by 4.3% in the second quarter. Swiss National Bank now owns 558,900 shares of the company’s stock valued at $214,115,000 after purchasing an additional 23,100 shares during the last quarter. National Pension Service increased its stake in shares of HCA Healthcare by 2.9% during the third quarter. National Pension Service now owns 626,585 shares of the company’s stock worth $267,051,000 after purchasing an additional 17,531 shares during the period. Savant Capital LLC boosted its stake in HCA Healthcare by 37.7% in the 3rd quarter. Savant Capital LLC now owns 4,548 shares of the company’s stock valued at $1,938,000 after purchasing an additional 1,246 shares during the period. Finally, Sector Gamma AS increased its position in HCA Healthcare by 36.0% during the 3rd quarter. Sector Gamma AS now owns 10,883 shares of the company’s stock worth $4,638,000 after buying an additional 2,883 shares during the period. Institutional investors and hedge funds own 62.73% of the company’s stock.

Analyst Upgrades and Downgrades

HCA has been the topic of a number of recent research reports. Morgan Stanley lowered shares of HCA Healthcare from an “equal weight” rating to an “underweight” rating and set a $425.00 price target on the stock. in a research report on Monday, December 15th. Wells Fargo & Company increased their target price on shares of HCA Healthcare from $452.00 to $481.00 and gave the stock an “equal weight” rating in a research report on Friday, January 30th. TD Cowen boosted their price target on HCA Healthcare from $529.00 to $561.00 and gave the company a “buy” rating in a research note on Tuesday, March 10th. Oppenheimer lifted their price objective on HCA Healthcare from $500.00 to $540.00 and gave the company an “outperform” rating in a report on Wednesday, January 28th. Finally, Deutsche Bank Aktiengesellschaft increased their target price on HCA Healthcare from $500.00 to $558.00 and gave the stock a “buy” rating in a report on Wednesday, January 28th. Sixteen investment analysts have rated the stock with a Buy rating, eight have given a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average target price of $537.73.

HCA Healthcare Price Performance

NYSE HCA opened at $533.39 on Monday. HCA Healthcare, Inc. has a fifty-two week low of $313.21 and a fifty-two week high of $556.52. The stock has a market capitalization of $119.28 billion, a PE ratio of 18.79, a PEG ratio of 1.64 and a beta of 1.34. The business has a fifty day moving average price of $507.05 and a two-hundred day moving average price of $470.48.

HCA Healthcare (NYSE:HCA) last announced its quarterly earnings data on Tuesday, January 27th. The company reported $8.01 earnings per share for the quarter, topping the consensus estimate of $7.37 by $0.64. The business had revenue of $19.51 billion during the quarter, compared to the consensus estimate of $19.67 billion. HCA Healthcare had a negative return on equity of 409.11% and a net margin of 8.97%.HCA Healthcare’s revenue for the quarter was up 6.7% on a year-over-year basis. During the same period in the prior year, the company earned $6.22 EPS. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. As a group, sell-side analysts expect that HCA Healthcare, Inc. will post 24.98 earnings per share for the current year.

HCA Healthcare Increases Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, March 31st. Investors of record on Tuesday, March 17th will be paid a $0.78 dividend. This represents a $3.12 annualized dividend and a yield of 0.6%. The ex-dividend date of this dividend is Tuesday, March 17th. This is a positive change from HCA Healthcare’s previous quarterly dividend of $0.72. HCA Healthcare’s payout ratio is currently 10.15%.

Insider Activity at HCA Healthcare

In other HCA Healthcare news, EVP Michael R. Mcalevey sold 1,694 shares of the stock in a transaction dated Wednesday, February 18th. The stock was sold at an average price of $533.37, for a total value of $903,528.78. Following the completion of the transaction, the executive vice president directly owned 8,853 shares in the company, valued at approximately $4,721,924.61. This trade represents a 16.06% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, SVP Christopher F. Wyatt sold 4,000 shares of the company’s stock in a transaction that occurred on Wednesday, February 11th. The shares were sold at an average price of $505.00, for a total value of $2,020,000.00. Following the completion of the transaction, the senior vice president directly owned 44,379 shares of the company’s stock, valued at $22,411,395. This represents a 8.27% decrease in their position. The SEC filing for this sale provides additional information. In the last ninety days, insiders sold 15,214 shares of company stock worth $7,797,595. Corporate insiders own 1.30% of the company’s stock.

HCA Healthcare Profile

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.